During the 2025-26 cold and #flu season, bioMérieux Sr. Director of Medical Affairs John Hurst speaks to the importance of fighting antimicrobial resistance in healthcare settings through rapid, accurate diagnostic testing. John’s advice for individuals? Practice good hygiene, get vaccinated, and look for answers, not antibiotics, when you’re sick. #antimicrobialresistance #AMR #diagnostic

How familiar are you with partnerships and collaborations between the laboratory and the diagnostics industry?

Antimicrobial resistance (AMR) and sepsis are among the greatest global health challenges of our time. In this 90-minute online session, leading experts, frontline clinicians, and a sepsis survivor come together to explore how antimicrobial stewardship can save lives – especially for patients with suspected or confirmed sepsis. Learn about global policy frameworks, real-world clinical implementation, frontline experiences, and the human impact of delayed diagnosis and resistant infections. ___ Chapter Markers: 00:00:00 Countdown 00:03:06 Prof. Tex Kissoon – Opening Remarks 00:05:47 Dr. Yvan J.-F. Huttin – From Policy to Practice: Strengthening Global Stewardship Frameworks for Sepsis and AMR 00:22:45 Prof. Alison Fox-Robichaud – Translating Antimicrobial Stewardship Into Clinical Practice: Lessons from Sepsis Care Pathways 00:43:13 Prof. Mervyn Mer – Aspects of Sepsis, AMR, and Antimicrobial Stewardship in Low- Resource Settings 01:09:19 Dr. Uzma Syed – The Perspective of a Clinician from the Frontline 01:28:15 Caroline Mtambalika – The Human Cost of Delayed Diagnosis and Resistant Infections 01:33:25 Panel Discussion, Q&A, and Closing Remarks ___ bioMérieux kindly sponsors this webinar. Don’t forget to like, share, and subscribe for more events from the Global Sepsis Alliance. ⸻ #WorldSepsisDay #AMR #Sepsis #Diagnostics #Innovation #GlobalHealth #antimicrobialresistance ⸻ 2025 Global Sepsis Alliance http://spkl.io/63324Ag33r http://spkl.io/63325Ag33T http://spkl.io/63326Ag33p http://spkl.io/63327Ag33V

Acute coronary syndrome (ACS) poses a signifcant burden worldwide; however, the development of high-sensitivity cardiac troponin (hs-cTn) assays has greatly improved patient management by enabling the detection of very low levels of troponin. The objective of this review was to identify current hs-cTn point-of-care (POC) assays, describe their key features, and discuss their analytical and clinical performance

The Global Sepsis Alliance is pleased to announce a special World Sepsis Congress Satellite Session on Antimicrobial Stewardship and Sepsis, taking place online on November 27, 2025, from 15:00 to 16:30 CET. Participation is free of charge, and healthcare professionals, policymakers, researchers, students, and advocates are warmly invited to register for free below.

This booklet aims to guide healthcare professionals through the process of developing and implementing a successful Antimicrobial Stewardship Program (ASP) in their hospital. The pragmatic “ASP Building Blocks” approach used in the booklet makes it a truly ‌“hands-on” resource and a must-read for ASP teams.

Explore essential strategies on drug dosing, Minimum Inhibitory Concentration (MIC), and therapeutic monitoring to improve patient care.

Join leading clinicians, researchers, and AMR experts for two powerful days of knowledge-sharing and connection. Empowered by bioMérieux Canada, the AMR

Rapid multiplex point-of-care (POC) PCR tests may reduce unnecessary antibiotic prescribing by quickly identifying viral etiologies in patients with acute respiratory infections (ARI). We evaluated the impact of a rapid (~15 min) multiplex PCR test on antibiotic prescribing, provider confidence, patient satisfaction, and emergency department (ED) length of stay (LOS).

An official journal of the Infectious Diseases Society of America. Publishes clinical, translational, and basic research findings focusing on the intersection of biomedical science and clinical practice.

With an ever-expanding portfolio of FDA-cleared devices for rapid AST directly from positive blood cultures, microbiology laboratories have more choices than ever.

One in six laboratory-confirmed bacterial infections causing common infections in people worldwide in 2023 were resistant to antibiotic treatments, according to a new World Health Organization (WHO) report launched today.

US infections caused by New Delhi metallo-β-lactamase–producing carbapenem-resistant Enterobacterales (NDM-CRE) increased by more than 460% from 2019 to 2023, according to a Centers for Disease Control and Prevention (CDC) analysis published in the Annals of Internal Medicine.1-2 The agency warns that limited access to carbapenemase testing is hindering detection, delaying targeted therapy, and likely undercounting the true burden. To explore the diagnostics angle, and how faster, broader testing can strengthen stewardship, John Osiecki, PhD, vice president, medical affairs in North America at bioMérieux, spoke to Contagion on this significant need.

bioMérieux collaborates with Henry Ford Health to host a summit tackling the escalating threat of antimicrobial resistance, uniting healthcare leaders to promote effective diagnostics and stewardship.